Royal Biologics Takes Diverse Approach to Autologous Live Cell Therapy
While autologous live cell therapies are not new, Royal Biologics is creating a unique value proposition through its growing ALC portfolio. Sep 22, 2021
Orthopedic Market Nears Normalization as 2021 Winds Down
The orthopedic market outperformed expectations in the first half of 2021, given gaps in vaccine coverage and the surging delta variant. Sep 08, 2021
MicroPort Orthopedics Expands Presence in China
The company grew nearly 30% in 1H21 but has not yet achieved volumes seen in 2019. MicroPort did, however, make important gains in China. Sep 02, 2021
AK Medical Hit by Volume-Based Procurement Turbulence
The company declined in the mid-single digits in 1H21 due to market instability caused by China's volume-based procurement policy. Aug 27, 2021
LimaCorporate Delivers Strong Top-Line Performance in First Half
In 2Q21, the company regained much of its pre-pandemic growth momentum except for a lagging recovery in Italy. Aug 26, 2021
Medtronic Opens Fiscal Year With Spine Share Gains
The company's FY 1Q22 saw double-digit growth in its spine business, driven by strength in biologics and recovering surgical volumes. Aug 25, 2021
Stryker Launches T2 Alpha Femur Retrograde Nailing System
Stryker has announced the launch of its T2 Alpha Femur Retrograde Nailing System, completing its lower extremity T2 Alpha Nailing platform. Aug 24, 2021
What Orthopedic Executives Said About 2Q21
Second-quarter commentary from ortho executives focused on acquisitions, knee replacement sales performance and enabling technology’s impact. Aug 18, 2021
Medartis Advances Strategic Expansion in US Market
The company grew nearly 30% in the first half of 2021, with important contributions coming from its growing presence in the U.S. market. Aug 18, 2021
Amplitude Surgical Looks to Rebuild Momentum
The company closed its 2021 fiscal year up high single digits compared to 2020 but is still well below historical norms. Aug 16, 2021
